Napredna pretraga

Pregled bibliografske jedinice broj: 908525

In vitro and in vivo antitumour effects of phenylboronic acid against mouse mammary adenocarcinoma 4T1 and squamous carcinoma SCCVII cells.


Marasović Maja; Ivanković Siniša; Stojković Ranko; Đermić Damir; Galić Borivoj; Miloš Mladen
In vitro and in vivo antitumour effects of phenylboronic acid against mouse mammary adenocarcinoma 4T1 and squamous carcinoma SCCVII cells. // Journal of enzyme inhibition and medicinal chemistry, 32 (2017), 1; 1299-1304 doi:10.1080/14756366.2017.1384823 (međunarodna recenzija, članak, znanstveni)


Naslov
In vitro and in vivo antitumour effects of phenylboronic acid against mouse mammary adenocarcinoma 4T1 and squamous carcinoma SCCVII cells.

Autori
Marasović Maja ; Ivanković Siniša ; Stojković Ranko ; Đermić Damir ; Galić Borivoj ; Miloš Mladen

Izvornik
Journal of enzyme inhibition and medicinal chemistry (1475-6366) 32 (2017), 1; 1299-1304

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Boron ; phenylboronic acid ; antitumour ; 4T1 cells ; SCCVII cells

Sažetak
The cytotoxic activity of phenylboroxine acid was evaluated in vitro on mouse mammary adenocarcinoma 4T1, mouse squamous cell carcinoma SCCVII, hamster lung fibroblast V79 and mouse dermal fibroblasts L929 cell lines. The cytotoxic effects were dose dependent for all tested tumour and non-tumour cell lines. Under in vivo conditions, three application routes of phenylboronic acid were studied: intra-peritoneal (i.p.), intra-tumour (i.t.) and per-oral. After tumour transplantation in syngeneic mice, phenylboronic acid was shown to slow the growth of both tumour cell lines (4T1 and SCCVII) compared with the control. The inhibitory effects were pronounced during the application of phenylboronic acid. For both tested tumour cell lines, the most prominent antitumour effect was obtained by intraperitoneal administration, followed significantly by oral administration.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Biologija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Projekt / tema
HRZZ-IP-2014-09-6897 - Istraživanje bioaktivnih spojeva iz dalmatinskogbilja: njihov antioksidacijski karakter i utjecaj na enzimsku inhibiciju i zdravlje (Mladen Miloš, )

Ustanove
Institut "Ruđer Bošković", Zagreb,
Sveučilište u Splitu

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati